www.fdanews.com/articles/114461-lundbeck-to-buy-ovation-pharmaceuticals-for-up-to-900-million
Lundbeck to Buy Ovation Pharmaceuticals for Up to $900 Million
February 9, 2009
Denmark’s H. Lundbeck said that it will buy Ovation Pharmaceuticals Inc. for up to $900 million. Lundbeck will make an upfront payment of $600 million upon closing.
MarketWatch
MarketWatch